Serum Proteomics Analysis for Sepsis
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01493466|
Recruitment Status : Unknown
Verified December 2011 by Chinese PLA General Hospital.
Recruitment status was: Recruiting
First Posted : December 16, 2011
Last Update Posted : December 16, 2011
|Condition or disease|
|SIRS Sepsis Severe Sepsis Death|
|Study Type :||Observational|
|Estimated Enrollment :||100 participants|
|Official Title:||Serum Proteomics Analysis for Dynamic Changes of Differential Proteins in Sepsis Patient With iTRAQ Labeling and LC-MS/MS|
|Study Start Date :||May 2010|
|Estimated Primary Completion Date :||March 2012|
|Estimated Study Completion Date :||March 2012|
normal person under physical examination
sepsis is defined as SIRS plus confirmed infection.
sepsis patients within 48 hours before death
- Survival status [ Time Frame: 28 days after admission to ICU ]The survival time of patients more than 28days is defined as survival. The survival time of patients less than 28days is defined as death.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01493466
|Contact: Longxiang Su, MD||+86 email@example.com|
|Chinese PLA General Hospital||Recruiting|
|Beijin, Beijing, China, 100853|
|Contact: Lixin Xie, MD firstname.lastname@example.org|
|Study Director:||Lixin Xie, MD||Department of Respiratory Diseases, Chinese PLA General Hospital|